Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network (Q73330865)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 May 2003
edit
Language Label Description Also known as
English
Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network
scientific article published on 01 May 2003

    Statements

    title
    Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    12721250
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12721250%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    3 November 2019
    Single-Agent Rituximab as First-Line and Maintenance Treatment for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma: A Phase II Trial of the Minnie Pearl Cancer Research Network (English)
    1 reference
    stated in
    Crossref
    DOI
    10.1200/JCO.2003.09.027
    reference URL
    https://api.crossref.org/works/10.1200/JCO.2003.09.027
    retrieved
    28 December 2023
    author name string
    cites work

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q73330865&oldid=2158151177"